Liraglutide and semaglutide improve cardiovascular and renal outcomes across baseline BP categories: analysis of LEADER and SUSTAIN 6 Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Leiter, L. A.; Bain, S. C.; Bhatt, D. L.; Buse, J. B.; Mazer, C. D.; Pratley, R.; Lindberg, S.; Rasmussen, S.; Vrazic, H.; Verma, S.

authors

Publication Date

  • September 1, 2019

webpage

published in

category

start page

  • S364

end page

  • S365

volume

  • 62